The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A microRNA-based gene dysregulation pathway in Huntington's disease
Abstract
Huntington's disease (HD) is a dominantly-inherited neurodegenerative disorder which is incurable and ultimately fatal. HD is characterised by widespread mRNA dysregulation, particularly in neurons of the forebrain, by mechanisms which are not fully understood. Such dysregulation has been demonstrated to result, in part, from aberrant nuclear localisation of the transcriptional repressor, REST. Here, we show that expression of a number of neuronal-specific microRNAs is also dysregulated in HD tissues, probably as a result of increased repression by REST. This phenomenon is observed in both murine models of HD and in the brains of human HD sufferers. MicroRNA loss is reflected in increased levels of a number of target messenger RNAs. These data are the first to demonstrate a role for microRNAs in HD, and indicate that the molecular aetiology of HD is reflected in a loss of neuronal identity, caused in part by dysregulation of both transcriptional and post-transcriptional mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In HD, dysregulation of miRNAs has been reported in HD in vitro models, transgenic HD animals and human HD brain.
“In HD, the dysregulation of miRNAs has been reported in HD in vitro models, transgenic HD animals and human HD brain [12-24].”
From miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement (2015) · cites this paper as [15]
miR-132-3p is down-regulated in human HD parietal cortical tissue and in brains of R6/2 and YAC128 HD mouse models.
“Concordant with our findings, miR-132-3p down-regulation in human HD parietal cortical tissue [15] and in brains of R6/2 and YAC128 HD mouse models has been observed [15,18].”
From miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement (2015) · cites this paper as [15]
Citations
Cites
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578
Regulation of miRNA expression during neural cell specification
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03978.x · Cited by 707
Flagged first, then by citations
Research works printed but not linked: 36
- Bae, 2005, Neuron, 47, 29, 10.1016/j.neuron.2005.06.005 · DOI
- Bartel, 2003, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
- Bilen, 2006, Mol. Cell, 24, 157, 10.1016/j.molcel.2006.07.030 · DOI
- Bingham, 2007, Mol. Cell. Biol., 27, 4082, 10.1128/MCB.00269-07 · DOI
- Borovecki, 2005, PNAS, 102, 11023, 10.1073/pnas.0504921102 · DOI
- Bruce, 2004, PNAS, 101, 10458, 10.1073/pnas.0401827101 · DOI · Paper page
- Cattaneo, 2005, Nat. Rev., Neurosci., 6, 919, 10.1038/nrn1806 · DOI
- Chen, 2006, Nat. Genet., 38, 228, 10.1038/ng1725 · DOI
- Cheong, 2005, Mol. Cell, 20, 45, 10.1016/j.molcel.2005.08.030 · DOI
- Conaco, 2006, PNAS, 103, 2422, 10.1073/pnas.0511041103 · DOI · Paper page
- Conti, 2005, PLoS Biol., 3, e283, 10.1371/journal.pbio.0030283 · DOI
- Crocker, 2006, Brain Res., 1088, 176, 10.1016/j.brainres.2006.02.102 · DOI
- Dunah, 2002, Science, 296, 2238, 10.1126/science.1072613 · DOI
- Esquela-Kerscher, 2006, Nat. Rev., Cancer, 6, 259, 10.1038/nrc1840 · DOI
- Greenway, 2007, Stem Cells, 25, 354, 10.1634/stemcells.2006-0207 · DOI
- Griffiths-Jones, 2004, Nucleic Acids Res., 32, D109, 10.1093/nar/gkh023 · DOI
- Hodges, 2006, Hum. Mol. Genet., 15, 965, 10.1093/hmg/ddl013 · DOI · Paper page
- Huang, 1998, Somat. Cell Mol. Genet., 24, 217, 10.1023/B:SCAM.0000007124.19463.e5 · DOI
- Johnson, 2006, Nucleic Acids Res., 34, 3862, 10.1093/nar/gkl525 · DOI
- Kim, 2007, Science, 317, 1220, 10.1126/science.1140481 · DOI · Paper page
- Kosik, 2006, Nat. Rev., Neurosci., 7, 911, 10.1038/nrn2037 · DOI
- Lim, 2005, Nature, 433, 769, 10.1038/nature03315 · DOI · Paper page
- Luthi-Carter, 2002, Hum. Mol. Genet., 11, 1911, 10.1093/hmg/11.17.1911 · DOI
- Mangiarini, 1996, Cell, 87, 493, 10.1016/S0092-8674(00)81369-0 · DOI · Paper page
- Nucifora, 2001, Science, 291, 2423, 10.1126/science.1056784 · DOI
- O'Donnell, 2005, Nature, 435, 839, 10.1038/nature03677 · DOI · Paper page
- Ooi, 2007, Nat. Rev., Genet., 8, 544, 10.1038/nrg2100 · DOI
- Palm, 1998, J. Neurosci., 18, 1280, 10.1523/JNEUROSCI.18-04-01280.1998 · DOI
- Rubinsztein, 2003, Trends Genet., 19, 233, 10.1016/S0168-9525(03)00074-X · DOI
- Schmittgen, 2004, Nucleic Acids Res., 32, e43, 10.1093/nar/gnh040 · DOI
- Sipione, 2002, Hum. Mol. Genet., 11, 1953, 10.1093/hmg/11.17.1953 · DOI · Paper page
- Steffan, 2000, PNAS, 97, 6763, 10.1073/pnas.100110097 · DOI
- Sood, 2006, PNAS, 103, 2746, 10.1073/pnas.0511045103 · DOI · Paper page
- Vo, 2005, PNAS, 102, 16426, 10.1073/pnas.0508448102 · DOI · Paper page
- Zuccato, 2003, Nat. Genet., 35, 76, 10.1038/ng1219 · DOI · Paper page
- Zuccato, 2007, J. Neurosci., 27, 6972, 10.1523/JNEUROSCI.4278-06.2007 · DOI · Paper page
Cited by
Sorted by citations
Advances in therapeutic applications of extracellular vesicles
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8521 · Cited by 1,039
Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2390-08.2008 · Cited by 679
Alterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C. B., & Liu, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013735 · Cited by 398
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model
Selvamani, A., Sathyan, P., Miranda, R. C., & Sohrabji, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032662 · Cited by 217
Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases
Wu, Y.-Y., & Kuo, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00636-z · Cited by 213
Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β
Schonrock, N., Ke, Y. D., Humphreys, D., Staufenbiel, M., Ittner, L. M., Preiss, T., & Götz, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011070 · Cited by 211
General Principals of miRNA Biogenesis and Regulation in the Brain
O'Carroll, D., & Schaefer, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.87 · Cited by 205
MiR-137: an important player in neural development and neoplastic transformation
Mahmoudi, E., & Cairns, M. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.150 · Cited by 198
MicroRNAs and neurodegeneration: role and impact
Abe, M., & Bonini, N. M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.013 · Cited by 190
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
Exosome-Based Delivery of miR-124 in a Huntington’s Disease Model
Lee, S.-T., Im, W., Ban, J.-J., Lee, M., Jung, K.-H., Lee, S. K., Chu, K., & Kim, M. (2017) · Journal of Movement Disorders · doi:10.14802/jmd.16054 · Cited by 164
Hoss, A. G., Labadorf, A., Latourelle, J. C., Kartha, V. K., Hadzi, T. C., Gusella, J. F., MacDonald, M. E., Chen, J.-F., Akbarian, S., Weng, Z., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0083-3 · Cited by 151
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110
Ghose, J., Sinha, M., Das, E., Jana, N. R., & Bhattacharyya, N. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023837 · Cited by 98
Rho GTPases in neurodegeneration diseases
DeGeer, J., & Lamarche-Vane, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.016 · Cited by 46
MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
Zhang, W.-H., Jiang, L., Li, M., & Liu, J. (2023) · Experimental Brain Research · doi:10.1007/s00221-022-06524-2 · Cited by 43
MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease
Ban, J.-J., Chung, J.-Y., Lee, M., Im, W., & Kim, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.040 · Cited by 36
Metadata
- Authors
- Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E., & Buckley, N. J.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 29
- Issue
- 3
- Pages
- 438-445
- ISSN
- 0969-9961
- Cited by
- 312
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review